Study design, materials and methods
From 2014 to 2023, LS-RPLND was performed on 189 patients at The N.N. Petrov National Medicine Research Center of oncology, including 67 laparoscopic surgeries in patients with disseminated TGCT after chemotherapy. Median age was 33±9.1 years. Patients with seminoma accounted for 9%, non-seminoma - 91%. Distribution by stages: Stage IA - 5 (7.46%); IB - 3 (4.48%); IS - 5 (7.46%); IIA- 31 (46.27%); IIB - 18 (26.87%); IIC - 5 (7.46%). The good prognosis group IGCCCG included 47 patients (70.15%), intermediate — 17 (25.37%), unfavorable — 3 patients (4.48%). The sizes of retroperitoneal lymph nodes by the maximum length in the axial plane: up to 2 cm - in 26 (38.8%) patients; up to 3 cm - 24 (35.8%); up to 4 cm - 14 (21%); up to 5 cm - 1 (1.4%); up to 6 cm - 2 (3%). According to CT: regression <50% with a decrease in size to 2 cm was noted in 50 (74.6%); up to 3 cm - 17 (25.4%).
Interpretation of results
There was a tendency towards a decrease in the incidence of complications (p=0.032) and a significant decrease in the risk of reoperation (p=0.031) after accumulating experience with LS-RPLND interventions, as well as the introduction of the fast track strategy since 2017.